Regulation (EC) No 816/2006 of the European Parliament and of the Council of 17 May 2006

on the compulsory licensing of patents relating to the manufacture of pharmaceutical products for export to countries with public health problems

AustriaBelgiumBulgariaCroatiaCyprusCzechiaDenmarkEstoniaFinlandFranceGermanyGreeceHungaryIrelandItalyLatviaLithuaniaLuxembourgMaltaNetherlandsPolandPortugalRomaniaSlovakiaSpainSweden
Regulation (EC) No 816/2006 of the European Parliament and of the Council of 17 May 2006 thumbnail

Regulation (EC) No 816/2006 contains provisions for compulsory licenses specifically for the export of pharmaceutical products to countries with public health problems. This applies to all Member States of the European Union (EU).

Applicable countriesAustria, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania, Slovakia, Spain, Sweden
Topic
Subtopics
Compulsory licensing provision
Pharmaceutical export provision
Original publication17 May 2006
Entered into force29 Jun 2006
Latest update29 Jun 2006
Relevant articles

Articles 1-20

Available languages
English Regulation (EC) No 816/2006 of the European Parliament and of the Council of 17/05/2006
French Réglement (CE) NO 816/2006 du Parlement Européen et du Conseil du 17 mai 2006
German Verordnung (EG) Nr. 816/2006 des EuropäIschen Parlaments und des Rates vom 17. Mai 2006
Italian Regolamento (CE) N. 816/2006 del Parlamento Europeo e del Consiglio del 17 maggio 2006
Spanish Reglamento (CE) NO 816/2006 del Parlamento Europeo y del Consejo de 17 de mayo de 2006
Georgetown University Center for Global Health Science and Security
International Disease and Events Analysis